Women's Experience of Premature Ovarian Insufficiency (POI) Diagnosis: Update on Actual Practices and Patient's Follow up
EMPOIHER
1 other identifier
observational
101
1 country
1
Brief Summary
Premature ovarian insufficiency (POI) affects 2,8 to 3,5% of women before the age of 40. Previous foreign studies revealed that only half of POI disclosures occurred during a medical consultation and that the diagnosis was often discussed in less than 5 minutes. As a result, most of patients felt a lack of information, and consequently sought data on the internet. None of these studies were conducted in France. The aim of this study is to analyze current practices related to POI diagnosis and to assess women's satisfaction
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 26, 2023
CompletedFirst Submitted
Initial submission to the registry
January 18, 2024
CompletedFirst Posted
Study publicly available on registry
January 29, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 19, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 19, 2024
CompletedMay 8, 2024
May 1, 2024
9 months
January 18, 2024
May 7, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
women's satisfaction
Women's satisfaction regarding POI disclosure will be evaluated using a standardized questionnaire specifically made for this study. Findings will be presented as a score based on 5 questions assessing patient's experience of POI diagnosis (Healthcare provider adjustments to patient's emotional state, speech clarity, information provided, opportunity to ask questions, relevance of the topics discussed based on the patient's concerns). For each question a score from 1 to 4 will be assigned (Very unsatisfied = 1 ; Unsatisfied = 2 ; Satisfied = 3 ; Very satisfied = 4), resulting in a total score ranging from 5 to 20. Patients scoring from 5 to 8 will be categorized as overall very unsatisfied, 9 to 12 as unsatisfied, 13 to 16 as satisfied, and 17 to 20 as very satisfied
Baseline
Secondary Outcomes (10)
Patient's expectations
Baseline
gynecological follow-up
Baseline
hormone replacement therapy
Baseline
interrupted HRT
Baseline
bone mineral density evaluation
Baseline
- +5 more secondary outcomes
Study Arms (1)
POI
Woman aged 18 years and older, diagnosed with POI following ESHRE 2016 criteria
Interventions
Standardized questionnaire specifically made for the study. The interview lasts approximately 15 minutes. The form gathers baseline characteristics of the patients such as socio-demographic information, symptoms, lifestyle factors and gynecological history. The questionnaire focuses also on the manner in which the diagnosis was revealed to the patient and their experience of this disclosure. Lastly, the questionnaire includes items issued from French practice guidelines concerning etiological investigations, fertility assessment, osteoporotic and cardiovascular complications, HRT use, and residual symptoms
Eligibility Criteria
Woman aged 18 years and older, diagnosed with POI following ESHRE 2016 criteria
You may qualify if:
- woman aged 18 years and older,
- diagnosed with POI following ESHRE 2016 criteria,
- speaking and reading French language,
- woman's oral consent,
- affiliated or beneficiary of health insurance.
You may not qualify if:
- iatrogenic POI (surgery, radiotherapy, chemotherapy linked),
- chromosomic POI (Turner Syndrome),
- inability for the woman to understand the nature or risks or significance and implications of the study,
- woman under legal protection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU Bordeaux
Bordeaux, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 18, 2024
First Posted
January 29, 2024
Study Start
July 26, 2023
Primary Completion
April 19, 2024
Study Completion
April 19, 2024
Last Updated
May 8, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share